Press Release

The IRB Barcelona spin-off Ona Therapeutics hits the road thanks to Sabadell Asabys

Based at the Barcelona Science Park, the company focuses on the development of a new drug for the treatment of metastatic cancer. The Sabadell Asabys Fund, which belongs to Asabys Partners, has invested € 1.5M into the company in order to start a venture round that could reach € 20M. Ona Therapeutics, a spin-off from IRB Barcelona and ICREA, has been founded by researchers Salvador Aznar-Benitah and Valerie Vanhooren after receiving investment from Sabadell Asabys.

Read more